DSN LINK STABLECARRIER WAVE LOCKORBITAL INDEX HOTSIGNAL CLOCK SYNCLOW NOISE FLOORFRAME BUFFER ONLINE
Loading
DSN LINK STABLECARRIER WAVE LOCKORBITAL INDEX HOTSIGNAL CLOCK SYNCLOW NOISE FLOORFRAME BUFFER ONLINE
Loading portal core
47 articles
In Asia-Pacific lung cancer screening, AI is no longer a futuristic add-on but a practical attempt to catch tumors that escape old risk lists.
Drugs routinely used against anemia are now showing up as an unexpected oncology signal, but for now as a laboratory lead rather than a finished treatment recommendation.
Finnish researchers have used artificial intelligence to accelerate colorectal cancer sample analysis and assess how the cellsâ DNA repair machinery works.
Eosinophils are no longer just an allergy footnote: a new review places them among the cells that could help read how tumors respond to immunotherapy.
On the International Space Station, NASA is now testing not just biology in orbit, but whether part of future medical manufacturing can move from the lab bench into microgravity.
Pain in neurofibromatosis type 1 may not begin with a tumor on the nerve, but earlier, in disrupted signaling between Schwann cells and sensory nerves.
The FDA has expanded treatment options for one of the hardest newly diagnosed AML groups: older and clinically frailer adults for whom intensive induction chemotherapy is not a realistic route.
AI radiotherapy planning is no longer just a lab demonstration: in the ARCHERY trial, it reached a high standard in more than 95% of cervical cancer cases.
An AI avatar doctor used before a real oncology appointment could become a practical tool for lowering stress and closing understanding gaps for cancer patients.
Houston Methodist has used a personalized mRNA vaccine in a patient with osteosarcoma in an attempt to reduce relapse risk under FDA compassionate use.
Research published in JAMA Network Open links psilocybin plus psychotherapy with more cocaine-free days in people with cocaine use disorder.
A new mouse study suggests that restoring an animal's own youthful gut microbiome can slow biological liver aging and reduce early cancer-linked risk signals.
Transferring a gene tied to protective hyaluronic acid production from naked mole rats into mice produced a modest but scientifically important result: the animals lived longer and showed fewer signs of biological decline.
Researchers linked a set of SP genes to regeneration in axolotls, zebrafish and mice, opening an early path to understanding tissue repair.
University of Illinois researchers demonstrated an MRI framework that measures more than 20 brain biomarkers in one scan.
A new tumor-on-a-chip model does not promise a cure for pancreatic cancer, but it sharpens the view of why the tumorâs tissue environment protects it so stubbornly.
A new preclinical study changes an old assumption: for mRNA vaccines, the key is not only which antigen is delivered, but where the body expresses it.
MSK researchers link two genomic signals to resistance against CDK4/6 inhibitors in metastatic breast cancer.
Dynamic42's BBB-on-chip model is being used to study glioblastoma treatment, with a focus on the blood-brain barrier.
A study in *GEN News* identifies tunneling nanotubes as a key pathway for mutant huntingtin protein transfer in brain cells.
Researchers at Worcester Polytechnic Institute have developed a flexible optical fiber that can be used to destroy hard-to-reach tumors on the vocal folds.
Researchers have identified specific biomarkers linked to digestive diseases, which can be analyzed using AI to predict various conditions.
Researchers used CRISPR and epigenetic targeting to reactivate silenced tumor suppressors in AML mouse models, reducing leukemia burden.
A *Nature Medicine* correction to a 2026 whole-genome sequencing study in solid cancers offers no explanation for the changes, leaving clinicians to parse its implications alone.
STAT News analysis reveals the FDAâs âbreakthroughâ AI devices lean toward broad-impact solutions over niche tools.
Keratinocytes in the epidermis donât just detect threatsâthey broadcast them via a newly identified pathway, Chinese researchers revealed in *Nature Immunology* this week.
Jean-Jacques Lebrun, Ph.D., led the team that made the breakthrough discovery of a protein that pancreatic cancer cells rely on to survive and grow.
Over 80% of variants detected in tumor sequencing fall into a gray zoneâneither clearly harmful nor benignâwhere Hiroshima Universityâs new tool aims to impose order.
Over 50% of women with disabilities prefer self-collected HPV tests, per a Journal of Medical Screening study.
Gotistobart increased survival in PRESERVE-003 for metastatic squamous NSCLC patients resistant to immunochemotherapy.
Students in Beijing are renting AI glasses for exam cheating, while startups cash in on $6 daily fees with zero hardware upgrades.
New prototype analyzes thousands of molecules simultaneously.
Scientists identify 95% fatality rate for small cell lung cancer patients.
Australia's Centre for Cancer Biology exposed CD47 as glioblastoma's growth engine, not just an immune shield, yet clinical translation stays distant.
New blood test detects 90% of early-stage pancreatic cancer cases with four-marker panel.
Novartis drops $3B on SNV4818, a PI3Kα inhibitor claiming pan-mutant coverageâwhere alpelisibâs toxicity and modest efficacy leave room for a rival.
*E. coli* Nissle, a gut-friendly probiotic, now doubles as a tumor-infiltrating drug manufacturer in lab mice.
A new study suggests metastatic cells can push healthy lung cells to produce lipids that support tumor growth.
A Boston surgical team rehearsed a high-risk pediatric procedure on a digital twin of the patientâs heart before making the first incision.
Gene mutations disrupt cortical layer formation in early brain development.
A consortium led by CASP founder John Moult is launching an AI-driven initiative to systematically audit publishedbiological research facing a reproducibility crisis.
Lecanemab, a key Alzheimer's drug, has been found to activate immune cells through the Fc fragment of the antibody, according to researchers.
New method measures cancerâs hidden gene-splicing toolkit, proving tumors weaponize RNA editing to fuel growth and survival.
PALPABLE wants to return palpation to minimally invasive surgery: a soft robotic fingertip that reads tissue stiffness while the surgeon works through instruments.
Ipsen's decision to pull Tazverik affects thousands of patients worldwide.
A breast cancer study mapped 78 paired tumors and metastases, showing how metabolically reprogrammed cells suppress immune response in lymph nodes.
